Med Clinical Medicine And Therapeutics Association Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 13.51%
(FY 2022)
- Ebitda 2.04%
(FY 2022)
- Net Worth -21.24%
(FY 2022)
- Total Assets -19.83%
(FY 2022)
About Med Clinical Medicine And Therapeutics Association
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pallavi Sengar and Hemendra Singh serve as directors at the Company.
- CIN/LLPIN
U85300RJ2020NPL067708
- Company No.
067708
- Company Classification
Private Not For Profit Company
- Incorporation Date
08 Jan 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Med Clinical Medicine And Therapeutics Association?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pallavi Sengar  | Director | 08-Jan-2020 | Current |
| Hemendra Singh | Director | 08-Jan-2020 | Current |
Financial Performance of Med Clinical Medicine And Therapeutics Association.
Med Clinical Medicine And Therapeutics Association, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 13.51% increase in profit. The company's net worth observed a substantial decline by a decrease of 21.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Med Clinical Medicine And Therapeutics Association?
In 2022, Med Clinical Medicine And Therapeutics Association had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Med Clinical Medicine And Therapeutics Association?
Unlock and access historical data on people associated with Med Clinical Medicine And Therapeutics Association, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Med Clinical Medicine And Therapeutics Association, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Med Clinical Medicine And Therapeutics Association's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
